Videos

In the final segment of this five-part series, A CMC Roadmap to Cell and Gene Therapies, Derrick McVicker, group leader, at PPD Laboratory services, GMP Lab, discusses the transfer of bioanalytical methods to GMP Lab.

Transfer of Bioanalytical Methods to the GMP Lab

An interview with Tom Sellig the Chief Executive Officer of Adare Pharma Solutions at the CPHI Conference in Frankfurt, Germany. 

The Journey to Building a Client Centric CDMO

This is the first segment of this three-part PPD Tech Talk series on Improving Clinical Trials with Innovative Data Solutions featuring experts Olivia Aspite and Bryan Neth of PPD®, part of Thermo Fisher Scientific.

Improving Clinical Trials with Innovative Solutions

This is the second segment of this three-part PPD Tech Talk series on Improving Clinical Trials with Innovative Data Solutions featuring experts Chris Clendening and Tim Rich.

The Intersection of Decentralized Trials and the Central Labs: Direct to Patient & Direct from Patient Shipments

This is the final segment of this three-part PPD Tech Talk series on Improving Clinical Trials with Innovative Data Solutions featuring experts John Maier and Renay Perry of PPD®, part of Thermo Fisher Scientific. 

Accelerating Clinical Trials and Reducing Human Error through Innovative Data Solutions

Building an API Manufacturing Model that Ensures Quality and Reliability

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

This video is an interview with Jon Brice, Vice President of Business Development at Asymchem at the AAPS Conference in Boston, Massachusetts.

 Asymchem Interview (AAPS 2022)

 Captisol- Why it’s the UNRIVALED Modified Cyclodextrin

Premium Empty Hard Capsules – EMBO CAPS® is for companies that want the best

Interview with Simon Tasker, CEO

Learn about the benefits of tailored active pharmaceutical ingredient [API] nanoparticles in this webinar with Christopher P. Worrall, Ph.D. This presentation looks at how API nanoparticles enable patient-centric therapies and benefit many dosage forms, as well as how industry collaborations drive novel drug delivery approaches.

The Benefits of Tailored API Nanoparticles Webinar

Learn how TargTex partners with Nanoform to produce therapies for Glioblastoma patients. This process includes identifying novel targets with small molecules, utilizing Nanoform technology to increase the active pharmaceutical ingredient [API] concentration, and improving treatment stability to move the drug to clinical development.

The Importance of the Proof-of-Concept Stage while Producing a Glioblastoma Multiform Drug Candidate Video

What does Ascendia do?

What sets Ascendia apart from its competitors?

What is Ascendia's company culture like?

Meet Ascendia Pharmaceuticals

Pharmaceutical Technology speaks with Jennifer Hurst, senior director at MasterControl.

Meet MasterControl

CURIS® provides portable and fixed decontamination systems. CURIS® has revolutionized the biodecontamination world with efficacious hybrid hydrogen peroxide decontamination, which delivers a mix of vapor and micro-aerosols to each space at precisely calibrated intervals. Recent challenges in staffing for Life Sciences inspired CURIS® to help labs save time and money by creating a single system that completes multiple decontamination tasks in virtually any space, including as an integrated system for on-demand biodecontamination.

Sponsored Videos